Blood Glucose Test Strips Market Set to Surpass USD 18 Billion by 2031 as Diabetes Epidemic Drives Global Demand | DataM Intelligence

The Global Blood Glucose Test Strips Market reached USD 11.0 billion in 2022 and is expected to reach USD 18.8 billion by 2031, growing at a CAGR of 5.96% during the forecast period 2024-2031. This robust growth is primarily driven by the escalating global prevalence of diabetes, increasing awareness and emphasis on regular glucose monitoring for disease management, improving healthcare infrastructure in developing regions, and significant innovations in test strip technology that enhance ease-of-use and accessibility for a growing patient population.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/blood-glucose-test-strips-market?jd

North America: Key Industry Developments (Largest Region)
✅ November 2025: The U.S. Centers for Medicare & Medicaid Services (CMS) announced the expansion of its coverage policy for blood glucose monitoring supplies, now including continuous glucose monitor (CGM) sensors and compatible test strips for a broader range of Type 2 diabetes patients, significantly boosting market volume.
✅ October 2025: LifeScan IP Holdings, LLC. (maker of OneTouch) launched a new direct-to-consumer subscription service in the U.S. and Canada, providing monthly deliveries of personalized strip quantities with integrated digital coaching via its OneTouch Reveal® app, aiming to improve adherence.
✅ September 2025: Roche Diabetes Care and Walgreens announced a nationwide partnership to offer free HbA1c screenings with the purchase of a specified number of Accu-Chek test strips. This initiative combines point-of-care testing with essential supply access to improve early diagnosis and ongoing management.

Asia-Pacific: Key Industry Developments (Fastest Growing Region)
✅ November 2025: The Indian government, under its National Non-Communicable Disease (NCD) program, initiated a large-scale public procurement tender for over 500 million thick-film test strips annually, aiming to provide free monitoring supplies to low-income diabetic patients across primary health centers.
✅ October 2025: ARKRAY, Inc. (Japan) and Ascensia Diabetes Care (holder of the Contour brand) formed a strategic alliance to co-develop and distribute a new ultra-low-cost, Bluetooth-enabled test strip and meter system specifically for the high-volume markets of Southeast Asia and India.
✅ September 2025: A consortium of Chinese digital health startups, led by a major player in telemedicine, launched an integrated "Test-to-Treat" platform. The service bundles generic-brand test strips with virtual doctor consultations and prescription delivery, capturing the rapidly growing self-management segment.

Key Mergers and Acquisitions (2025):
✅ A leading pharmaceutical distributor acquires a generic test strip manufacturer: In October 2025, to secure its supply chain and expand its private-label portfolio, a major global pharmaceutical distributor completed the acquisition of a mid-sized manufacturer specializing in low-cost, FDA/CE-approved thick-film strips.
✅ DarioHealth Corp. partners with a large health insurer: In September 2025, DarioHealth Corp., known for its all-in-one meter and app ecosystem, entered an exclusive partnership with a major U.S. health insurer. The deal provides the insurer's members with subsidized Dario kits and strips, integrating real-time glucose data directly into chronic care management programs.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=blood-glucose-test-strips-market (Purchase 2 or more Reports and get 50% Discount)

Market Segmentation Analysis:
-By Strip Type: Thick Film Strips Lead with Dominant Share
Thick Film Strips account for the dominant 56.4% of the market share. Their leadership is attributed to a superior combination of cost-effectiveness, reliable accuracy, durability, and ease of mass production, making them the most accessible and widely used technology for the vast majority of diabetic patients globally, especially in price-sensitive markets.
Thin Film and Optical strips serve niche segments where ultra-precision or specific form factors are required, but they are outpaced by the economic and practical advantages of thick-film technology for routine monitoring.

-By End-User: Homecare Settings Command Largest Portion
Homecare/self-monitoring is the overwhelmingly dominant end-user segment. The fundamental need for daily, and often multiple-times-daily, blood glucose checks to manage insulin therapy, diet, and activity makes the home the primary consumption point for test strips.
Hospitals, Diagnostic Centers, and Ambulatory Surgical Centers utilize test strips for point-of-care testing, initial diagnosis, and inpatient management, but their volume is dwarfed by the ongoing, chronic needs of the outpatient population.

-By Diabetes Type: Type-II Diabetes Drives Core Demand
Type-II Diabetes accounts for the vast majority (90-95%) of global diabetes cases. The sheer size of this patient population, combined with growing guidelines recommending regular self-monitoring even for non-insulin-dependent patients, makes it the primary driver of test strip demand.
Type-I Diabetes, Gestational Diabetes, and Prediabetes are significant and growing segments, each with specific monitoring protocols that contribute to steady market demand.

Growth Drivers:
1. Rising Global Diabetes Pandemic: The single most powerful driver is the inexorable increase in the number of people diagnosed with diabetes worldwide, fueled by aging populations, urbanization, sedentary lifestyles, and rising obesity rates, directly expanding the addressable patient base.
2. Growing Emphasis on Preventive Care and Glycemic Control: Increased awareness among patients and healthcare providers about the critical importance of tight glucose control to prevent devastating complications (e.g., neuropathy, retinopathy, kidney disease) is driving more frequent testing.
3. Improving Healthcare Access and Reimbursement Policies: Expansion of health insurance coverage and government subsidy programs for diabetes supplies in both developed and emerging economies is removing cost barriers and enabling wider adoption of regular testing.
4. Technological Integration and Digital Health Trends: The convergence of test strips with smartphone connectivity, apps, and cloud-based data platforms is adding value, improving patient engagement, and facilitating remote patient monitoring, making traditional strips part of a modern digital health ecosystem.
5. Increasing Diagnosis Rates and Awareness Campaigns: Public health initiatives and screening programs are identifying millions of previously undiagnosed diabetic and prediabetic individuals, who then enter the market as new users of monitoring supplies.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/blood-glucose-test-strips-market?jd

Regional Insights:
North America holds the largest market share, driven by a high prevalence of diabetes, excellent reimbursement frameworks (Medicare, Medicaid, private insurance), high patient awareness, and the presence of nearly all major global manufacturers. The U.S. is the world's most valuable single market for these products.
Asia-Pacific is the fastest-growing region, fueled by its massive population base, rapidly increasing diabetes incidence (particularly in India and China), improving economic conditions, and expanding government healthcare initiatives aimed at combating the diabetes epidemic. This region represents the future growth engine of the global market.

Key Players:
Roche Diabetes Care Limited | LifeScan IP Holdings, LLC. (OneTouch) | ARKRAY, Inc. | Ascensia Diabetes Care Holdings AG (Contour) | B. Braun SE | AgaMatrix (maker of meters for Walgreens, etc.) | Universal Biosensors | HMD Biomedical Inc. | DarioHealth Corp. | Abbott Laboratories

Key Highlights (Top 5 Key Players) for Blood Glucose Test Strips Market:
1. Roche Diabetes Care (Accu-Chek) is a global powerhouse with a deeply entrenched presence in hospitals, pharmacies, and home care. Its strength lies in a comprehensive ecosystem of meters, strips, and digital tools, backed by strong brand trust and extensive clinical support for healthcare professionals.
2. LifeScan IP Holdings, LLC. (OneTouch) is a consumer-facing leader renowned for its simple, reliable meters and strips. Its direct-to-consumer initiatives and focus on digital integration and adherence through its OneTouch Reveal platform position it strongly in the competitive retail and managed care markets.
3. Abbott Laboratories (though not listed in the source, is a critical player) dominates the diabetes monitoring space with its FreeStyle Libre continuous glucose monitoring (CGM) system. While CGM is an alternative, Abbott's massive market presence influences the competitive landscape for traditional strips, and it also supplies strips for its FreeStyle Precision line of traditional meters.
4. ARKRAY, Inc. is a leading innovator and manufacturer, particularly strong in the Asia-Pacific region. It is known for high-quality, clinically accurate devices and strips and often operates as a key OEM (Original Equipment Manufacturer) and supplier for other brands and private-label products globally.
5. Ascensia Diabetes Care (Contour) differentiates itself through advanced smart technology and second-chance sampling. Its Contour Next line of meters and strips is consistently rated among the most accurate, and its Contour Diabetes app ecosystem provides robust data management, appealing to tech-savvy users and healthcare providers.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?jd

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.